DESCRIPTION (Adapted from applicant's abstract): This research project
involves the development of experimental methods for detecting less
receptive nuclei with special emphasis placed on 13C and 15N. The
application of such methods to biologically important system and their
theoretical consequences are stressed. The value of chemical shifts in
structural correlations of liquid samples has been very well documented
and these concepts are now being developed in the shielding tensor. The 3D
aspects of shielding tensors becomes one of the significant aspects of
this proposal. Solid state work on either powders or single crystals is
required to obtain shielding tensors and their principal orientations in
the molecular frame. Use of tensor data along with theory is advancing our
understanding of the origins of chemical shielding and its use in shift
structure correlations. The expansion from a isotropic shift to six tensor
parameters in solids provides details unavailable in liquids.
Thus, work will be directed towards the development of single crystal
methods for biomolecules of a size not here-to-fore possible. Recent
advances of a 2D magic angle turning (MAT) experiment now provides a
method for obtaining solid power patterns for compounds with 2-3 dozen
different carbons. Several new modifications have been developed to better
address structural problems. These include two 3-D PHORMAT experiments.
One is a separated local field and also a CS-CS-CS 3D PHORMAT spectrum.
A new technique for importing greater evaluation resolution, TIGER, is
reducing the time necessary for acquiring PHORMAT data on any complex
molecules. A combination of these methods is providing shift tensor
information on a variety of biomolecules important in biomedical
applications. Use of Dynamic Nuclear Polarization (DNP) from unpaired
electrons with 15N detection indicates that enhancement factors of about
2 orders of magnitude may be possible for a large number of compounds. As
15N shifts exhibit even greater dependence upon structural effects than
13C, this enhancement portends well for 15N chemical shifts of
biomolecules. Thus, the extension to use both 14N and 13C offers a
significant opportunity to expand our long term 13C program.
No Sub Projects information available for 5R01GM008521-40
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM008521-40
Patents
No Patents information available for 5R01GM008521-40
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM008521-40
Clinical Studies
No Clinical Studies information available for 5R01GM008521-40
News and More
Related News Releases
No news release information available for 5R01GM008521-40
History
No Historical information available for 5R01GM008521-40
Similar Projects
No Similar Projects information available for 5R01GM008521-40